Sérgio Cimerman

Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil

Sérgio Cimerman, Alberto Chebabo, Clóvis Arns da Cunha et al. · The Brazilian Journal of Infectious Diseases · 2020 · 143 citations · Full text

Veterinary Medicine, Health Policy, Infectious Diseases +14

Prevalence of intestinal parasitic infections in patients with acquired immunodeficiency syndrome in Brazil

Sérgio Cimerman, Benjamin Cimerman, David Salomão Lewi · International Journal of Infectious Diseases · 1999 · 123 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Guidelines for the pharmacological treatment of COVID-19. The task force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology

Maicon Falavigna, Verônica Colpani, Cinara Stein et al. · Revista Brasileira de Terapia Intensiva · 2020 · 120 citations · Full text

Medicine, Infectious Diseases, Pharmacology +7

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

Vinicius Fontanesi Blum, Sérgio Cimerman, James Hunter et al. · EClinicalMedicine · 2021 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide

Ángel A. Escobedo, G. Álvarez, M. E. González et al. · Annals of Tropical Medicine and Parasitology · 2008 · 64 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +9